[go: up one dir, main page]

DE69609054D1 - Ein prozess für die herstellung von faktor ix biologischen ursprungs - Google Patents

Ein prozess für die herstellung von faktor ix biologischen ursprungs

Info

Publication number
DE69609054D1
DE69609054D1 DE69609054T DE69609054T DE69609054D1 DE 69609054 D1 DE69609054 D1 DE 69609054D1 DE 69609054 T DE69609054 T DE 69609054T DE 69609054 T DE69609054 T DE 69609054T DE 69609054 D1 DE69609054 D1 DE 69609054D1
Authority
DE
Germany
Prior art keywords
pct
factor
production
biological origin
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69609054T
Other languages
English (en)
Other versions
DE69609054T2 (de
Inventor
Djuro Josic
Lutz Hoffer
Frank Morfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octapharma AG
Original Assignee
Octapharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma AG filed Critical Octapharma AG
Priority to DE69609054T priority Critical patent/DE69609054T2/de
Publication of DE69609054D1 publication Critical patent/DE69609054D1/de
Application granted granted Critical
Publication of DE69609054T2 publication Critical patent/DE69609054T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE69609054T 1995-02-25 1996-02-14 Ein prozess für die herstellung von faktor ix biologischen ursprungs Expired - Lifetime DE69609054T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE69609054T DE69609054T2 (de) 1995-02-25 1996-02-14 Ein prozess für die herstellung von faktor ix biologischen ursprungs

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19506633A DE19506633A1 (de) 1995-02-25 1995-02-25 Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
DE69609054T DE69609054T2 (de) 1995-02-25 1996-02-14 Ein prozess für die herstellung von faktor ix biologischen ursprungs
PCT/EP1996/000636 WO1996027003A1 (en) 1995-02-25 1996-02-14 A process for the preparation of factor ix from biological sources

Publications (2)

Publication Number Publication Date
DE69609054D1 true DE69609054D1 (de) 2000-08-03
DE69609054T2 DE69609054T2 (de) 2001-03-08

Family

ID=7755037

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19506633A Ceased DE19506633A1 (de) 1995-02-25 1995-02-25 Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
DE69609054T Expired - Lifetime DE69609054T2 (de) 1995-02-25 1996-02-14 Ein prozess für die herstellung von faktor ix biologischen ursprungs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19506633A Ceased DE19506633A1 (de) 1995-02-25 1995-02-25 Verfahren zur Herstellung von Faktor IX aus biologischen Quellen

Country Status (20)

Country Link
US (1) US5919909A (de)
EP (1) EP0811058B1 (de)
JP (1) JPH11500910A (de)
KR (1) KR100436857B1 (de)
CN (1) CN1105779C (de)
AT (1) ATE194167T1 (de)
AU (1) AU697217B2 (de)
CA (1) CA2213577C (de)
DE (2) DE19506633A1 (de)
DK (1) DK0811058T3 (de)
EA (1) EA000222B1 (de)
ES (1) ES2147365T3 (de)
FI (1) FI119377B (de)
GR (1) GR3034035T3 (de)
IL (1) IL117157A (de)
MY (1) MY119366A (de)
PT (1) PT811058E (de)
UA (1) UA46005C2 (de)
WO (1) WO1996027003A1 (de)
ZA (1) ZA961450B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
JP4855074B2 (ja) * 2003-09-30 2012-01-18 一般財団法人化学及血清療法研究所 高純度血液凝固ｉｘ因子調製物およびその精製方法
KR100567448B1 (ko) * 2003-11-05 2006-04-04 주식회사 인투젠 형질전환 동물의 유즙 전처리방법 및 이를 통한 인체단백질의 정제방법
WO2005094873A1 (en) 2004-03-19 2005-10-13 Baxter International Inc. Factor ixa for the treatment of bleeding disorders
US10434492B2 (en) * 2007-01-26 2019-10-08 Sigma-Aldrich Co. Llc Compositions and methods for solid phase extraction of lipids
US10928366B2 (en) * 2007-01-26 2021-02-23 Sigma-Aldrich Co. Llc Compositions and methods for combining protein precipitation and solid phase extraction
JP5876868B2 (ja) * 2010-03-30 2016-03-02 オクタファルマ・アーゲー 第ｉｘ凝固因子などのビタミンｋ依存性タンパク質の精製方法
CN104560925B (zh) * 2014-12-30 2017-11-03 山东泰邦生物制品有限公司 一种从人凝血因子ⅸ层析废液中激活制备人凝血酶的方法
CN107540743A (zh) * 2017-10-11 2018-01-05 南岳生物制药有限公司 一种双层析法制备人纤维蛋白原的方法
CN111378029B (zh) * 2018-12-29 2023-05-05 四川远大蜀阳药业有限责任公司 一种人凝血因子ix的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE36457T1 (de) * 1983-05-02 1988-09-15 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern.
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
ATE195877T1 (de) 1991-03-01 2000-09-15 Rhone Poulenc Rorer Int Herstellung von faktor-ix
CA2155337A1 (en) 1993-02-09 1994-08-18 Monika Stadler Method for inactivating viruses devoid of lipid envelopes
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen

Also Published As

Publication number Publication date
PT811058E (pt) 2000-10-31
WO1996027003A1 (en) 1996-09-06
JPH11500910A (ja) 1999-01-26
UA46005C2 (uk) 2002-05-15
EP0811058A1 (de) 1997-12-10
ATE194167T1 (de) 2000-07-15
FI973469L (fi) 1997-08-22
CA2213577A1 (en) 1996-09-06
DK0811058T3 (da) 2000-10-16
KR19980702453A (ko) 1998-07-15
AU4876196A (en) 1996-09-18
CN1181782A (zh) 1998-05-13
FI973469A0 (fi) 1997-08-22
ZA961450B (en) 1996-08-27
AU697217B2 (en) 1998-10-01
EA199700196A1 (ru) 1998-02-26
US5919909A (en) 1999-07-06
ES2147365T3 (es) 2000-09-01
IL117157A0 (en) 1996-06-18
EP0811058B1 (de) 2000-06-28
CA2213577C (en) 2005-01-04
IL117157A (en) 1999-12-22
MY119366A (en) 2005-05-31
GR3034035T3 (en) 2000-11-30
KR100436857B1 (ko) 2004-09-21
CN1105779C (zh) 2003-04-16
EA000222B1 (ru) 1998-12-24
FI119377B (fi) 2008-10-31
DE19506633A1 (de) 1996-08-29
DE69609054T2 (de) 2001-03-08

Similar Documents

Publication Publication Date Title
DE60230274D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des pts-g
DE69530242D1 (de) Verfahren zur Herstellung von Glutaminsäure durch Fermentation
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
DE3855525D1 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
DE69609054D1 (de) Ein prozess für die herstellung von faktor ix biologischen ursprungs
DE59609824D1 (de) Verfahren zur herstellung von substituierten arylmilchsäure-haltigen cyclodepsipeptiden mit 24 ringatomen
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE60011396D1 (de) Verfahren zur herstellung von iopamidol
ATE224379T1 (de) Ein verfahren zur herstellung von 1,4,7,10- tetraazacyclododecan-1,4,7-triessigsäure und deren derivaten
ATE373014T1 (de) Einen nanofiltrationsschritt umfassendes verfahren zur aufreinigung von albumin, lösung und zusammensetzung zur therapeutischen anwendung,die dieses enthalten
ATE101846T1 (de) Verfahren zur herstellung von 1,1dichlorotetrafluorethan.
DE69010256D1 (de) Verfahren zur Herstellung von L-Ornithin durch Fermentation.
DE59701415D1 (de) Verfahren zur herstellung von celluloseformkörpern und die mit diesem verfahren hergestellten formkörper sowie deren verwendung
DE59603295D1 (de) Verfahren zur herstellung von dolastatin 15 und deren zwischenprodukten
DE69009394D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
DE69804850D1 (de) Verfahren zur herstellung eines kappa-casein-glykomakropeptides oder eines abkoemmlings davon
DE69513408D1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl-lipopeptiden
DE59803194D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
DE59008482D1 (de) Verfahren zur Herstellung von 2,4,5-Triamino-6-hydroxypyrimidin durch katalytische Hydrierung von 2,4-Diamino-6-hydroxy-5-nitrosopyrimidin.
ATE81013T1 (de) Verfahren zur herstellung von faktor viii:cmangelplasma und ein so erhaltenes mangelplasma.
DE59007022D1 (de) Verfahren zur kontinuierlichen Herstellung von Nylon 4,6.
DE59809481D1 (de) Verfahren zur Herstellung von Aminocyanacetamid
DE69802171T8 (de) Verfahren zur Herstellung von 5,6-Dihydro-11H-dibenzo[a,d]cyclohept-11-enen
DE59605866D1 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
ATE221550T1 (de) Beschleuniger für die herstellung von polyamiden aus aminonitrilen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: OCTAPHARMA AG, LACHEN, CH

8364 No opposition during term of opposition